WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
93.75
-2.29 (-2.38%)
Mar 3, 2026, 3:00 PM CST
53.36%
Market Cap 287.35B
Revenue (ttm) 43.88B
Net Income (ttm) 14.99B
Shares Out 2.96B
EPS (ttm) 4.65
PE Ratio 19.00
Forward PE 15.45
Dividend 0.70 (0.71%)
Ex-Dividend Date Sep 26, 2025
Volume 36,272,286
Average Volume 34,644,537
Open 96.32
Previous Close 96.04
Day's Range 93.68 - 97.95
52-Week Range 48.48 - 115.79
Beta 0.62
RSI 43.44
Earnings Date Mar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 37,832
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.